Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Michael
M
Pignone
Mark J
MJ
Alberts
John A
JA
Colwell
Mary
M
Cushman
Silvio E
SE
Inzucchi
Debabrata
D
Mukherjee
Robert S
RS
Rosenson
Craig D
CD
Williams
Peter W
PW
Wilson
M Sue
MS
Kirkman
D000572:American Heart Association; D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D048909:Diabetes Complications / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012955:Societies, Medical; D014481:United States
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin